Overall Score

Financial Health

Liquidity remains tight with a current ratio of 0.65 and negative working capital of -$35.0M.

Leverage is still low, with net debt to EBITDA at just 0.07x and debt-to-assets at 1.27%.

Cash generation is positive, but free cash flow yield is only 5.2% and income quality is weak at -4.52.

Profitability

Margins remain weak, with EBIT margin at -11.0% and net margin at -10.8%.

Returns are still negative across ROA (-5.8%), ROE (-9.8%), and ROIC (-5.4%).

Gross margin is thin at 7.3%, limiting operating flexibility.

Valuation

Valuation remains mixed at 4.9x sales and 19.1x free cash flow.

The company screens expensive on book value at 4.6x and EV/EBITDA is elevated at 53.7x.

Negative earnings keep the P/E ratio distorted, limiting usefulness of earnings-based valuation.

Operational Efficiency

Cash conversion is roughly neutral, with a cash conversion cycle of -0.8 days.

Receivables and payables are balanced, with DSO at 53.0 days and DPO at 53.7 days.

Asset turnover is acceptable at 0.53x, but working capital turnover remains negative due to negative working capital.